Category Archives: Business of Biotech

The Search for Meaningful Work in Biotechnology

250px-AquaBountyTechnologiesLogo

The time to begin your search for a rewarding employment position is the day you register to go to a post-secondary institution. Why? Because the whole point of getting educated is to be able to apply what you learned in school in a job that values the knowledge and skills that you have developed. Getting educated is an investment in your future. Finding challenging and rewarding employment is the reward for that investment. When you Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

BIO Adds Airgas to Membership Discount Program

BIO-Business-Solutions-RGB

BIO Business Solutions®, BIO’s cost savings program, has announced a new partnership with Airgas, an Air Liquide company.  The Airgas program, available to members of BIO and our state affiliates, offers a broad range of industrial, specialty and medical gases in all modes of supply; dry ice; cryogenic storage and gas handling equipment and supplies. The program provides preferred pricing on gas products and 10-25% preferred discounts on equipment and supplies and the ability to customize Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Are You Ready To Go Beyond The Cutting Edge At BIO 2016?

biocon

In an April 18 blog posted on Life Science Leader, Rob Wright outlined the essential components of a compelling and educational panel for the 2016 BIO International Convention. Wright will be moderating a Super Session panel on Tuesday, June 7 from 11:15 AM–12:30 PM called Beyond the Cutting Edge: How to Enable Life Science Organizations Today for the Societal Challenges of Tomorrow.  The session will focus on innovation and knowledge transfer opportunities across disciplines as well as industries. Wright asks readers to provide Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Do Outcomes Matter When There Is Chronic Misalignment?

synthetic biology

This piece by Allan L. Shaw was originally published in Life Science Leader. With over $3 trillion in annual healthcare spending, a relatively young population, and shorter life expectancies than other western nations, one would think there would be vast opportunities for the U.S. healthcare industry to rein in costs, weed out inefficiency, and improve outcomes. Instead of yielding to “regression toward the mean,” however, the highest global per capita healthcare machine marches to 20 Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , ,

Biomarkets: Looking For The Hole In The Donut

synthetic biology

This piece by Allan L. Shaw was originally published in Life Science Leader. The biopharma sector has enjoyed increased market success over the last few years. And while some may be tempted to bask in the optimistic “bio-euphoria,” others question whether the industry might be in the midst of a market bubble. What led to this current period of biopharma success, despite the industry’s inherent risks (e.g. scientific, clinical, regulatory, and commercial)? Several factors contributed Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , ,